Vector Purification Market is driven by increasing demand for gene therapies
The vector purification market comprises reagents and systems used for purification and separation of viral vectors used as gene delivery vehicles. Viral vectors such as adenovirus, adeno-associated virus, lentivirus, retrovirus, herpes simplex virus, and others are widely utilized in gene therapy, vaccines, and immunotherapy applications due to their ability to deliver genetic materials inside cells. Vector purification involves density gradient centrifugation, column chromatography, precipitation, and filtration techniques to obtain highly pure viral vectors devoid of impurities that could impact transfection efficiency or safety. The growing R&D in gene therapy development has created a strong need for high-quality vector purification systems to extract large quantities of vectors from producer cells.
The vector purification market is estimated to be valued at USD 336 Mn in 2024 and is expected to reach USD 1,300 Mn by 2031, growing at a compound annual growth rate (CAGR) of 21.3% from 2024 to 2031.
The demand for Vector Purification Market is growing due to the increasing number of gene therapy clinical trials and new product launches. More than 2000 gene therapy clinical trials conducted globally are boosting the need for high-quality and high-yield vector purification.
Get more insights on: Vector Purification Market
Get this Report in Japanese Language: ベクター精製市場
Get this Report in Korean Language: 벡터 정화 시장
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian